Anti-Microbial Savior BioteQ Co., Ltd. (TPEX:6864)

TPEX:6864 Revenue

Anti-Microbial Savior BioteQ had revenue of 842.00K TWD in the half year ending June 30, 2026, with 57.38% growth. This brings the company's revenue in the last twelve months to 1.26M, up 115.23% year-over-year. In the year 2025, Anti-Microbial Savior BioteQ had annual revenue of 706.00K with 15.36% growth. That makes Anti-Microbial Savior BioteQ the 46,660th largest company in the world by revenue and 2,199th in Taiwan.

• Revenue (ttm): 1.26M
• Revenue Growth: +115.23%
• P/S Ratio: 1,595.69
• Revenue / Employee: 38.12K
• Employees: 33
• Market Cap: 1.89B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	706.00K	94.00K	15.36%
Dec 31, 2024	612.00K	-116.00K	-15.93%
Dec 31, 2023	728.00K	-1.97M	-73.01%
Dec 31, 2022	2.70M	2.61M	2,964.77%
Dec 31, 2021	88.00K	15.00K	20.55%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 8, 2026

Data Sources Report a data error